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Abstract: We reported two forms (sphere and wire) of newly fabricated chlorhexidine 
(CHX)-loaded mesoporous silica nanoparticles (MSNs), and investigated their releasing capacities 
and anti-biofilm efficiencies. The interactions of the blank MSNs with planktonic oral microor-
ganisms were assessed by field emission scanning electron microscopy. The anti-biofilm effects 
of the two forms of nanoparticle-encapsulated CHX were examined by 2,3-bis (2-methoxy- 
4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide. The profiles of biofilm penetration were 
analyzed by fluorescent-labeled MSNs using confocal microscopy and ImageJ. The spherical MSNs 
with an average diameter of 265 nm exhibited a larger surface area and faster CHX-releasing rate 
than the MSN wires. The field emission scanning electron microscopy images showed that both 
shaped MSNs enabled to attach and further fuse with the surfaces of testing microbes. Meanwhile, 
the nanoparticle-encapsulated CHX could enhance the anti-biofilm efficiency with reference to its 
free form. Notably, the spherical nanoparticle-encapsulated CHX presented with a greater anti-
biofilm capacity than the wire nanoparticle-encapsulated CHX, partly due to their difference in 
physical property. Furthermore, the relatively even distribution and homogeneous dispersion of 
spherical MSNs observed in confocal images may account for the enhanced penetration of spherical 
nanoparticle-encapsulated CHX into the microbial biofilms and resultant anti-biofilm effects. These 
findings reveal that the spherical nanoparticle-encapsulated CHX could preferably enhance its anti-
biofilm efficiency through an effective releasing mode and close interactions with microbes.
Keywords: mesoporous silica nanoparticles, morphology, chlorhexidine, imaging, biofilms
Introduction
In recent years, nanotechnology has been increasingly used in the development of a 
broad range of biomedical agents and approaches. Among different types of inorganic 
nanomaterials, the mesoporous silica nanoparticles (MSNs) exhibit many unique fea-
tures, such as large surface area, high pore volume, stable physicochemical property, 
and flexible surface modification, which make MSN a potential drug delivery vehicle.1 
Previous in vitro and in vivo studies have reported the promising capacity of MSNs as 
anticancer and antibacterial drug delivery systems.2–6 Moreover, our group has recently 
successfully encapsulated the most commonly used antimicrobial agent in dentistry, 
chlorhexidine (CHX), into commercial MSNs (MCM-41), and further confirmed their 
antibacterial and anti-biofilm efficiencies via an effective releasing mode.7
There are plenty of studies on how the nanoparticle morphology, size, and surface 
modifications affect their interactions with the mammal cells.8,9 Currently, there are 
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limited reports on the interactions of MSNs with the microbes 
and especially the possible effects of nanoparticle morphol-
ogy on microbial activities. Hence, we herewith reported the 
physical characterization of two representative morphologies 
(sphere and wire) of newly fabricated CHX-loaded MSNs, 
and evaluated their releasing capacities and anti-biofilm effi-
ciencies. Additionally, the fluorescent MSNs were prepared 
as a tracking tool to further investigate the diffusion profiles 
of the MSNs into the microbial biofilms.
Materials and methods
chemicals
Cetyltrimethylammonium bromide (CTAB), 3-aminopro-
pyltriethoxysilane (APTES), rhodamine B isothiocyanate 
(RITC), and CHX were purchased from Sigma-Aldrich Co. 
(St Louis, MO, USA). Tetraethyl orthosilicate (TEOS) was 
purchased from Acros Organics (Thermo Fisher Scientific, 
Waltham, MA, USA). Aqueous ammonia was purchased 
from VWR (Radnor, PA, USA). Hydrochloric acid (37%) 
was purchased from RCI Labscan (Bangkok, Thailand).
Microorganisms
The oral microorganisms Streptococcus sobrinus (ATCC 
33478), Streptococcus mutans (ATCC 35668), and Candida 
albicans (SC5314) were obtained from the archival collection 
of Department of Oral Biosciences, Faculty of Dentistry, 
University of Hong Kong. S. sobrinus and S. mutans were 
inoculated on horse blood agar plates (Oxoid, Thermo Fisher 
Scientific) with 5% horse blood (Hemostat Laboratories, 
Dixon, CA, USA) and incubated in anaerobic chamber with 
5% CO
2
, 10% H
2
, and 85% N
2
 at 37°C. C. albicans were cul-
tured on Sabouraud dextrose agar (Thermo Fisher Scientific) 
and incubated aerobically at 37°C. Before the assays, the 
microorganisms were suspended in brain heart infusion (BHI) 
broth (Oxoid) (for bacteria) or yeast nitrogen base (YNB) 
broth (Difco, Franklin Lakes, NJ, USA) containing 50 mM 
glucose (for C. albicans) overnight before using.
Synthesis and characterization of MSNs
Different shaped MSNs were prepared by adjusting the 
CTAB concentration in ammonia-catalyzed TEOS hydrolysis 
reaction. Briefly, a certain amount of CTAB was dissolved 
completely in the water at 30°C to get the clear solution. 
After adding the ammonia, TEOS was mixed with 10 mL 
ethanol and then dropped at a rate of 1 mL/min with vigorous 
stirring (250 rpm/min) for 5 hours at room temperature. The 
spherical MSNs (S-MSNs) were synthesized as described by 
Yu et al10 with some modifications, and the weight or volume 
of the reactants was 0.364 g (CTAB): 180 mL (H
2
O): 5 mL 
(NH
3
⋅H
2
O): 1.56 mL (TEOS). For the MSN wires (W-MSNs), 
the reactant amount was 0.8 g (CTAB): 200 mL (H
2
O): 
3.5 mL (NH
3
⋅H
2
O): 1 mL (TEOS). The well-synthesized 
MSNs were obtained by centrifugation at 6,000 rpm for 
10 minutes using centrifuge 5804 (Eppendorf, Hamburg, 
Germany). The surfactant was removed in acidic ethanol by 
sonication (20 minutes) twice, and the residue was confirmed 
by infrared spectrometry. The particle morphology and pore 
structure were observed under LEO1530 field emission 
scanning electron microscopy (FE-SEM; Carl Zeiss Meditec 
AG, Jena, Germany) and Tecnai G2 20 S-TWIN transmis-
sion electron microscopy (FEI, Hillsboro, OR, USA). The 
nanoparticle surface areas and pore size were analyzed by N
2
 
adsorption–desorption isotherms at about 77 K using ASAP 
2020M system (Micromeritics, Norcross, GA, USA).
chX loading and releasing
The CHX solution (2 mg/mL) was freshly prepared by dis-
solving 0.02 g of CHX in 10 mL of hot ethanol. In all, 0.1 g 
of well-synthesized MSNs was subsequently immersed in 
the CHX solution with physical stirring at room temperature 
for 24 hours. We harvested nanoparticle-encapsulated CHX 
(Nano-CHX) by centrifugation at 6,000 rpm for 10 minutes 
and washed them with water and ethanol, once each. The 
final products were obtained after oven drying at 90°C and 
denoted as S-CHX and W-CHX for spherical nanoparticle-
encapsulated CHX and wire nanoparticle-encapsulated CHX, 
respectively. The loading efficiencies of CHX in S-/W-CHX 
were determined by TGA-6 Thermogravimetric Analyzer 
(TGA; PerkinElmer Inc., Waltham, MA, USA). Both the load-
ing process and TGA determination were repeated for three 
times to compare the loading capacity of two different shaped 
MSNs. Referring to the releasing profiles of S- and W-CHX, 
10 mg of both shaped Nano-CHX was dispersed in 5 mL of 
distilled water and then shaken at 37°C. At each time point, the 
releasing system was centrifuged to collect the supernatant, 
and subsequently re-suspended in 5 mL of distilled water 
again. The absorbance of the supernatant was measured at 
254 nm by Cary UV-100 UV/visible absorption spectroscopy 
(Agilent Technologies, Santa Clara, CA, USA).
Surface modification and fluorescent 
labeling of MsNs
MSNs (0.5 g) were dispersed in 100 mL of ethanol and 
refluxed with 1.25 mL of APTES overnight in nitrogen. 
The amine-modified MSNs were centrifuged and washed 
with ethanol twice to remove the unreacted APTES. Then, 
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the fluorescent MSNs were prepared by a reaction between 
RITC and the amine groups on the modified MSNs.11 The 
air-dried amine-MSNs (0.2 g) were dispersed in 40 mL of 
ethanol containing 5 mg of RITC with vigorous stirring for 
4 hours at room temperature. The fluorescent-labeled MSNs 
were washed with ethanol for three times and collected by 
centrifugation at 6,000 rpm for 5 minutes (Eppendorf). 
The vacuum-dried final products were denoted as RITC-S-
MSNs and RITC-W-MSNs, respectively. The fluorescent 
intensities of RITC-S-/RITC-W-MSNs (100 μg/mL) and 
RITC (28 μg/mL) in ethanol were determined by LS 50B 
fluorescence spectrometer (PerkinElmer Inc.).
Field emission scanning microscopy
Briefly, 0.5 mL of bacteria (106 cells/mL) or yeast 
(103 cells/mL) suspension and 0.5 mL of S-/W-MSNs disper-
sion (200 μg/mL) were mixed in the sterilized plastic tubes 
and incubated at 37°C for 24 hours. Then, the mixture was 
processed by vortexing (Stuart Auto Vortex Mixer SA2, Rhys 
International Ltd, Greater Manchester, UK) for 3 seconds. 
In all, 10 μL of the suspensions was taken out and dropped 
on the coupons. The following fixation was accomplished as 
described by Allan-Wojtas et al.12 The well-prepared speci-
mens were subsequently mounted on aluminum stabs with 
copper tape, coated with palladium with an ion sputter coater 
(JEOL JFC1 100; JEOL, Tokyo, Japan). The interaction 
between the nanoparticles and microorganisms was visual-
ized using FE-SEM (LEO1530; Carl Zeiss Meditec AG).
Inhibition effect of Nano-CHX on 1-day 
biofilms and XTT assay
As previously described, S. sobrinus and S. mutans were 
cultured in BHI broth and incubated overnight. Then the bac-
teria were centrifuged and washed with phosphate-buffered 
saline (PBS) twice and re-suspended with BHI at a concen-
tration of 109 cells/mL. In all, 200 μL of the well-prepared 
cell suspension was subsequently pipetted in 96-well plates 
and incubated in the anaerobic chamber. After 24 hours, the 
bacteria biofilms were washed with PBS to remove loosely 
attached cells.7 C. albicans was cultured to form biofilms as 
described by Chandra et al.13 The overnight broth-cultured 
C. albicans was centrifuged and washed with PBS twice and 
then re-suspended in YNB containing 100 mM glucose at a 
concentration of 107 cells/mL. The cells were then inoculated 
into the 96-well plates and allowed to attach to the plate 
bottom at 37°C, 80 rpm for 90 minutes. Then, the biofilms 
in the early stage were aspirated to remove the non-adherent 
yeast cells and washed gently with PBS twice and then 
matured in YNB containing 100 mM glucose. After 24 hours 
of incubation, both the 1-day-old bacterial and yeast biofilms 
were treated with CHX, S-/W-CHX (containing same drug 
amount as free CHX at each concentration), and S-/W-MSNs 
(blank nanoparticles with same weight as S-/W-CHX) in 
different concentrations for 24 hours. After the treatment, 
the biofilms were washed gently with 100 μL of PBS, and 
their vitalities were measured by a 2,3-bis (2-methoxy-4-
nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT) 
reduction assay with some modifications.14 Then, 200 μL 
of freshly prepared reaction agent (XTT + menadione) was 
added into each well. After 3 hours of incubation at 37°C in 
the dark, the supernatant of each well was transferred into a 
new plate and then the plate was assessed at 490 nm using a 
microplate reader (SpectraMax M2; Molecular Devices LLC, 
Sunnyvale, CA, USA). All of the assays were performed on 
three different occasions in triplicate.
Confocal scanning laser microscopy
The 1-day-old biofilms were prepared in the chambered cover 
glass (μ Slide 8 well; ibidi GmbH, Munich, Germany), as 
described previously. Before the treatment, the RITC-S-/
RITC-W-MSNs were dispersed in BHI broth or YNB 
containing 100 mM glucose by sonication for 10 minutes. 
Then the RITC-S-/RITC-W-MSNs dispersions were added 
to the biofilms followed by 24-hour incubation. The treated 
biofilms were subsequently washed in PBS once to remove 
the free nanoparticles and then stained with SYTO-9 (Live/
Dead BacLightTM Viability Kit; Thermo Fisher Scientific) 
for 30 minutes in the dark at room temperature. The images 
of the fluorescent MSNs in the biofilms were visualized by 
an Olympus FLUOVIEW FV 1000 confocal scanning laser 
microscope with FV-10 ASW system (Olympus Corpora-
tion, Tokyo, Japan). This microscope equipped with 543 nm 
HeNe laser and 488 nm Argon laser were used to obtain the 
red signals from RITC-labeled MSNs and green signals of 
SYTO-9, respectively. The image analysis was performed 
with FV10-ASW 4.0 Viewer (Olympus Corporation) and 
ImageJ. Briefly, the biofilm images with multiple layers 
were projected over z-axis and transformed into tiff format. 
The images of red channel, which represents the distribution 
of RITC-MSNs, were opened with ImageJ to calculate the 
number of particles, average size, and percentage of RITC-
MSN area.
Statistical analysis
The significance of CHX and two different shaped Nano-
CHX against the biofilms was analyzed by one-way analysis 
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of variance, with multi-comparisons by Tukey’s test using 
GraphPad Prism 6.
Results
Characterization of S-/W-MSNs, S-/W-
chX and rITc-s-/rITc-W-MsNs
The FE-SEM images showed that the diameter of S-MSNs 
was 265±30 nm, while the width and length of W-MSNs were 
53±11 and 477±152 nm, respectively (Figure 1A and B). The 
well-ordered pore structures were visualized in transmission 
electron microscope. The nitrogen adsorption/desorption 
measurement revealed that S-MSNs had a relatively larger 
surface area (860.52 vs 559.42 m2/g) but similar pore size 
(2.86 vs 2.88 nm), as compared with W-MSNs (Figure 2).
The loading efficiency of S-CHX (20.1%±0.7%) was 
greater than that of W-CHX (15.8%±1.7%) but without statisti-
cal significance. It is worthy to note that their releasing profiles 
varied. Overall, an initial burst was observed on the two forms 
of Nano-CHX releasing profiles in the first 8 hours. However, 
S-CHX released more amount of CHX with reference to 
W-CHX after 48 hours (34.0% vs 22.2%) (Figure 3). Mean-
while, only a small amount of CHX was released from the 
nanoparticles within the experimental time, indicating fur-
ther releasing potential and prolonged effect of nanoparticle 
encapsulation. Additionally, the emission wavelength of the 
fluorescent MSNs shifted to 580 nm with reference to the free 
RITC (594 nm), due to the conjugation between the RITC and 
amine group on the particles (Figure 4).
Interactions of MsNs with the planktonic 
microbes
As shown in Figure 5, both S- and W-MSNs were found on 
the microbial surfaces. Notably, SEM displayed clearly that 
both the shapes of MSNs fused with the microbes tested. 
Comparably, obvious fusion between the S-MSNs and the 
microbes existed. The W-MSNs had a larger contact area than 
the S-MSNs with potentially increased interaction with the 
microorganisms, and it also enhanced the inter-attachment 
among the W-MSNs. As such, it may result in a more seri-
ous entanglement of W-MSNs than S-MSNs, and affect the 
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Figure 1 characterization of MsN spheres and wires.
Notes: Fe-seM images showing s-MsNs (A) with an average diameter of 265±30 nm and W-MSNs (B) with a width and length of 53±11 and 477±152 nm, respectively. 
TeM images of s-MsNs (C) and W-MsNs (D) and their pore shapes (E and F; G and H, respectively).
Abbreviations: Mag, magnification; MSNs, mesoporous silica nanoparticles; FE-SEM, field emission scanning electron microscope; S-MSNs, spherical mesoporous silica 
nanoparticles; W-MSNs, wire mesoporous silica nanoparticles; TEM, transmission electron microscopy.
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homogeneous dispersion of W-MSNs. Hence, it was found 
that the entangled W-MSNs could attach to small bacteria 
(1 μm in length) at the end points and relatively larger 
yeasts (2 μm in diameter) by the wires.
Anti-biofilm effects of S-CHX and 
W-chX
The S-/W-MSNs per se did not possess any detectable anti-
biofilm effects either on bacterial or yeast biofilms (Figure 6). 
For the monospecies biofilms of S. sobrinus, no significant 
difference was observed between CHX and both S- and 
W-CHX at the concentration of 25 and 100 μg/mL. Both 
the Nano-CHX treated groups showed lower absorbance 
compared to CHX (50 μg/mL) alone. For the biofilms of 
S. mutans, S-CHX exhibited the strongest inhibitory effect 
at 3.125 μg/mL. Interestingly, it exhibited potent anti-biofilm 
effects on C. albicans biofilms with reference to other groups 
of treatment at all tested concentrations.
Diffusion of fluorescent MSNs in 
microbial biofilms
The interactions of nanoparticles with the microbial biofilms 
were further investigated by confocal microscopy (Figure 7). 
Fluorescent MSNs presented with red dots could be observed 
in monospecies biofilms of S. sobrinus, S. mutans, and 
C. albicans. The penetration and distribution of RITC-MSNs 
$
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Figure 2 BeT nitrogen adsorption–desorption isotherms and BJh pore size distribution plots of MsN spheres and wires.
Notes: (A) surface area (860.52 m2/g) and pore size (2.86 nm; inset) of s-MsNs. (B) surface area (559.42 m2/g) and pore size (2.88 nm; inset) of W-MsNs.
Abbreviations: BET, Brunauer–Emmett–Teller; BJH, Barrett–Joyner–Halenda; MSNs, mesoporous silica nanoparticles; S-MSNs, spherical mesoporous silica nanoparticles; 
W-MSNs, wire mesoporous silica nanoparticles.
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Figure 3 Releasing profile of CHX from two different shaped nanoparticle-
encapsulated chX.
Notes: The release percentages of chX from s-chX and W-chX in distilled water 
at each time point were acquired by measuring the absorbance using UV-visible 
absorption spectroscopy at 254 nm.
Abbreviations: CHX, chlorhexidine; S-CHX, spherical nanoparticle-encapsulated 
chlorhexidine; W-CHX, wire nanoparticle-encapsulated chlorhexidine.
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Figure 4 Fluorescence emission spectra of fluorescent MSN spheres and wires.
Notes: After being excited at 543 nm, the emission wavelength of RITC-S-MSNs 
and rITc-W-MsNs (580 nm) showed a blue sift compared with rITc (594 nm).
Abbreviations: MSNs, mesoporous silica nanoparticles; RITC, rhodamine B 
isothiocyanate; RITC-S-MSNs, rhodamine B isothiocyanate-labeled spherical 
mesoporous silica nanoparticles; RITC-W-MSNs, rhodamine B isothiocyanate-
labeled wire mesoporous silica nanoparticles.
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were quantitatively analyzed using ImageJ (Table 1). Inter-
estingly, more spherical fluorescent MSNs were detected 
in the three forms of biofilms, while the RITC-W-MSNs 
aggregated greatly to form larger particles in the monospe-
cies biofilms. Moreover, the RITC-S-MSNs dispersed and 
distributed fairly evenly with larger detectable diffusion area 
with reference to the RITC-W-MSNs.
Discussion
The particle’s morphology, size, and pore volume are the 
critical factors to determine the surface area of the MSNs, 
which subsequently affect the drug loading efficiency.15 It 
is widely accepted that larger surface area and pore volume 
of nanoparticles provide more space for drug accommoda-
tion. In the present study, we found that S-CHX, which has 
a larger surface area, showed a tendency of higher loading 
efficiency than W-CHX, although the difference did not reach 
statistical significance. Next, both the shapes of nanoparticle 
encapsulation per se could extend CHX releasing up to 
48 hours. Notably, S-CHX showed a faster releasing rate 
than W-CHX in the time-course experiment. It could be due 
to the relatively large surface area of S-MSNs that increased 
contact area of the working solution with the nanoparticles, 
and subsequently promoted CHX diffusion from the pores 
of particles.16 Moreover, the entanglement was more com-
monly observed in W-MSNs than in S-MSNs since the former 
provided a relatively large contact area than the latter, which 
further decreased the surface area of W-MSNs and thereby 
may result in a slower CHX releasing profile.
The entanglement was further confirmed in the inter-
actions of MSNs with microorganisms. More agglomer-
ated W-MSNs were found than S-MSNs under FE-SEM, 
although the MSNs had been sonicated for 10 minutes before 
adding to the microbial suspensions. After co-incubation for 
24 hours, some MSNs were found to attach on the microbes. 
Moreover, the S-MSNs could be fused with the surfaces 
of microbes more obviously than the W-MSNs. Previous 
studies have examined the interactive profiles of nanopar-
ticles with bacteria and explored the underlying mecha-
nisms. The polyurethane nanoparticles generated from the 
prostheses were found on the cell wall of Staphylococcus 
aureus and in its cytoplasm.17 Besides the polyurethane 
nanoparticles, gold nanoparticles coated by citrate or bovine 
serum albumin are associated with the surface as well as 
the intracellular cytoplasm of Escherichia coli.18 It has also 
been well documented that the nanoparticles (quantum dots 
and metal oxides) could also be internalized by the bacteria 
other than by endocytosis.19,20 The quantum dots with mean 
diameter less than 6 nm can diffuse into bacteria through 
membrane pores.19 The metal nanoparticles with a large 
size could diffuse into the cells through the damage to cell 
membrane.21 Moreover, the conjugation of nanoparticles 
with different molecules may increase the internalization 
of large size nanoparticles.18 In the present study, the 
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Figure 5 Fe-seM images of the interactions of s-MsNs or W-MsNs with planktonic microorganisms.
Note: S. sobrinus (A-i and ii), S. mutans (B-i and ii), and C. albicans (C-i and ii). The arrows highlight the interactive spots of MsNs with microbes.
Abbreviations: FE-SEM, field emission scanning electron microscope; S-MSNs, spherical mesoporous silica nanoparticles; W-MSNs, wire mesoporous silica nanoparticles; 
S. sobrinus, Streptococcus sobrinus; S. mutans, Streptococcus mutans; C. albicans, Candida albicans; Mag, magnification; EHT, extra high tension; WD, working distance; 
MSNs, mesoporous silica nanoparticles.
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Figure 6 Absorbance (490 nm) of 1-day-old microorganism biofilms after being treated with free and two different shaped nanoparticle-encapsulated CHX (XTT assay).
Notes: (A) S. sobrinus, (B) S. mutans, and (C) C. albicans. s- and W-chX encapsulated with the same drug amount as the free chX. s- and W-MsNs were equivalent to 
s- and W-chX at each concentration. The values on the x-axes refer to the concentrations of free or nanoparticle-encapsulated chX. The lowercase letters above each 
bar (a, b, c, and d) indicate significant differences (P0.05) between the control and treatment groups.
Abbreviations: CHX, chlorhexidine; XTT, 2,3-bis (2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide; S. sobrinus, Streptococcus sobrinus; S. mutans, 
Streptococcus mutans; C. albicans, Candida albicans; S-CHX, spherical nanoparticle-encapsulated chlorhexidine; W-CHX, wire nanoparticle-encapsulated chlorhexidine; S-MSNs, 
spherical mesoporous silica nanoparticles; W-MSNs, wire mesoporous silica nanoparticles.
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Figure 7 confocal images of rITc-s-MsNs and rITc-W-MsNs (50 μg/ml for bacteria and 100 μg/mL for yeast) in 1-day-old microorganism biofilms after 24 hours of 
incubation.
Note: S. sobrinus (A-i and ii), S. mutans (B-i and ii), and C. albicans (C-i and ii).
Abbreviations: RITC-S-MSNs, rhodamine B isothiocyanate-labeled spherical mesoporous silica nanoparticles; RITC-W-MSNs, rhodamine B isothiocyanate-labeled wire 
mesoporous silica nanoparticles; S. sobrinus, Streptococcus sobrinus; S. mutans, Streptococcus mutans; C. albicans, Candida albicans.
blank MSN particles without any modification were used 
to investigate their interactions with cells. These blank 
nanoparticles per se have no antibacterial effects without 
damaging cellular membrane.7,22 Therefore, it is conceiv-
able that the blank MSNs with a relatively large size (more 
than 100 nm) could not diffuse into the cytoplasm by causing 
damage to the cell walls. In this study, the images captured 
by FE-SEM confirm the adhesion and fusion of the MSNs 
with the microorganisms, likely due to the biocompatibility 
between their hydroxyl groups and cell walls.
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Table 1 The number of nanoparticles, average size, and percentage 
of two different shaped rITc-MsNs areas in the monospecies 
biofilms of S. sobrinus, S. mutans, and C. albicans
Microbe/ 
nanoparticles
Number of  
nanoparticles
Average  
size (μm)
Area  
(μm2)
Area%
S. sobrinus
rITc-s-MsNs 2,031 3.5 7,259.3 7.2
rITc-W-MsNs 736 6.3 4,631.4 4.7
S. mutans
rITc-s-MsNs 2,101 2.6 5,477.0 5.5
rITc-W-MsNs 579 6.6 3,822.1 3.9
C. albicans
rITc-s-MsNs 1,894 4.5 8,519.4 8.6
rITc-W-MsNs 1,014 8.0 8,089.5 8.2
Notes: The number of nanoparticles, average size, and area% were calculated on 
the basis of the red channel of the confocal images. The number of nanoparticles 
represents the number of countable particles with fixed hue, saturation, and 
brightness.
Abbreviations: RITC-MSNs, rhodamine B isothiocyanate-labeled mesoporous 
silica nanoparticles; RITC-S-MSNs, rhodamine B isothiocyanate-labeled spherical 
mesoporous silica nanoparticles; RITC-W-MSNs, rhodamine B isothiocyanate-
labeled wire mesoporous silica nanoparticles; S. sobrinus, Streptococcus sobrinus; 
S. mutans, Streptococcus mutans; C. albicans, Candida albicans.
Both bacteria and yeasts can produce biopolymer 
matrix which contributes to form and develop microbial 
biofilms, thereby enhancing the antibiotic resistance of 
microorganism.23,24 Several hypotheses have been proposed 
to explain the biofilm resistance to antibiotics, such as drug 
exclusion by the biopolymer matrix and formation of per-
sisters.25 In order to tackle antibiotic resistance, lipid and 
polymer nanoparticles have been widely used as promising 
drug vehicles for delivering antibiotics into the biofilms.26 In 
addition, metal or metal oxide nanoparticles, such as silver, 
gold, iron oxide, and zinc oxide, have been developed to 
effectively control microbial biofilms through penetrating 
biopolymer matrix and causing damage to the cell walls.27–29 
Apart from the materials already mentioned, silica nano-
particles with nitric oxide donators also exhibit potent anti-
biofilm efficiency.6 Moreover, Slomberg et al found that the 
decreased size and increased aspect ratio could enhance the 
anti-biofilm efficiency of the NO-releasing silica nanoparti-
cles.5 However, in our study, W-CHX with wire shape did not 
show a better anti-biofilm efficiency than S-CHX, partly due 
to the entanglement of W-CHX that may restrict the release 
of CHX. The nanoparticle encapsulation per se still improves 
the anti-biofilm efficiency of CHX. It could be attributed to 
the protective effect of the nanoparticles on this anti-biofilm 
agent during the penetration of the biopolymer matrix. Addi-
tionally, Nano-CHX, especially S-CHX, appears to interact 
closely with microorganisms and releases the drug directly 
within the biofilms after the penetration. In this study, the 
penetration of Nano-CHX was further investigated indirectly 
by the fluorescent MSNs. Interestingly, these fluorescent 
MSNs can be found within the biofilms, while RITC-S-
MSNs could form smaller agglomerates and distribute more 
evenly than RITC-W-MSNs. Currently, many researchers 
have addressed the general steps of the interactions between 
the nanoparticles and biofilms, and how the surface modi-
fications could affect the penetration of particles into the 
biofilms.30 Although fluorescent MSNs and Nano-CHX have 
the same core structures, they remain to vary in the surface 
functional groups. This might result in the different interac-
tions with the biofilms. Hence, the development of hybrid 
nanoparticles with fluorescent groups on the surface and 
inside-encapsulated antibiotics is highly warranted for further 
studies on the pathways and performance of nanoparticles in 
their interactions with microbial biofilms.
In summary, the S-MSNs had a larger surface area 
and released encapsulated CHX faster than the W-MSNs. 
The SEM images showed that the S-MSNs could fuse and 
have closer interactions with the oral microorganisms than 
the W-MSNs. Both S-MSNs and W-MSNs could enhance the 
anti-biofilm efficiencies of CHX through effective nanopar-
ticle encapsulation. Moreover, the S-CHX exhibited a higher 
anti-biofilm activity than the W-CHX, since the entanglement 
of W-CHX could restrict the drug release and interactions 
with the microorganisms. The confocal images confirmed 
that the fluorescent MSNs were able to penetrate the biofilms, 
and RITC-S-MSNs showed relatively more homogeneous 
distribution than the RITC-W-MSNs. In conclusion, the 
present study reveals that S-CHX may preferably enhance its 
anti-biofilm efficiency through an effective releasing mode 
and close interactions with microbes.
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